Ergoteles LLC Werewolf Therapeutics, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.53 - $4.73 $134,783 - $416,684
-88,094 Reduced 76.87%
26,501 $54,000
Q3 2022

Nov 14, 2022
SELL
$4.14 - $7.42 $59,636 - $106,885
-14,405 Reduced 11.17%
114,595 $517,000
Q2 2022

Aug 12, 2022
BUY
$3.43 - $5.98 $442,470 - $771,420
129,000 New
129,000 $528,000

Others Institutions Holding HOWL

# of Institutions
72
Shares Held
32.2M
Call Options Held
53.8K
Put Options Held
1.3K
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $62.6M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email